Skip to main navigation Skip to search Skip to main content

Impact of the M184V Resistance Mutation on Virological Efficacy and Durability of Lamivudine-Based Dual Antiretroviral Regimens as Maintenance Therapy in Individuals With Suppressed HIV-1 RNA: A Cohort Study

  • Roberta Gagliardini*
  • , Arturo Ciccullo
  • , Alberto Borghetti
  • , Franco Maggiolo
  • , Dario Bartolozzi
  • , Vanni Borghi
  • , Monica Pecorari
  • , Antonio Di Biagio
  • , Anna Paola Callegaro
  • , Bianca Bruzzone
  • , Francesco Saladini
  • , Stefania Paolucci
  • , Renato Maserati
  • , Maurizio Zazzi
  • , Simona Di Giambenedetto
  • , Andrea De Luca
  • *Corresponding author
  • Azienda Ospedaliera Universitaria Senese
  • ASST Papa Giovanni XXIII
  • Azienda Ospedaliera Careggi
  • University of Modena and Reggio Emilia
  • San Martino Hospital Genoa
  • University of Siena
  • IRCCS Fondazione Policlinico San Matteo - Pavia

Research output: Contribution to journalArticle

Abstract

not available
Original languageEnglish
Pages (from-to)ofy113-N/A
JournalTHE EUROBIOTECH JOURNAL
Volume5
Issue number6
DOIs
Publication statusPublished - 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Oncology
  • Clinical Neurology

Keywords

  • M184V
  • NRTI mutations
  • dual therapy
  • integrase inhibitors
  • lamivudine

Fingerprint

Dive into the research topics of 'Impact of the M184V Resistance Mutation on Virological Efficacy and Durability of Lamivudine-Based Dual Antiretroviral Regimens as Maintenance Therapy in Individuals With Suppressed HIV-1 RNA: A Cohort Study'. Together they form a unique fingerprint.

Cite this